Skip to main content
Equibles

Candriam S.C.A.

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1537014 STRASSEN, N4
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$40,710,058
+$3,801,228 QoQ
Shares Held
1,092,301
-1.4% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#21
of 286 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. IDYA ranks #16 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 195,674 $122,010,565
2 RVMD
Revolution Medicines, Inc.
 556,392 $104,201,093
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 199,505 $99,100,118
4 ALNY
Alnylam Pharmaceuticals, Inc.
 314,512 $94,677,547
5 ONC
BeOne Medicines Ltd.
 289,735 $82,565,782
6 COGT
Cogent Biosciences, Inc.
 2,088,369 $80,819,880
7 ARGX
Argenx SE
 80,120 $74,332,932
8 ROIV
Roivant Sciences Ltd.
 1,990,510 $70,444,148

All Filings in IDYA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $40,710,058 1,092,301
2026-03-31 $36,908,830 1,107,708
2025-09-30 $27,562,832 1,012,967
2025-06-30 $19,220,688 914,400
2025-03-31 $15,367,338 938,177
2024-12-31 $27,545,901 1,071,825
2024-09-30 $29,793,139 940,440
2024-06-30 $22,084,857 629,019
2024-03-31 $27,645,233 630,019
2023-12-31 $14,054,776 395,019
2023-09-30 $11,601,912 430,019
2023-06-30 $9,635,470 410,020
2023-03-31 $3,848,751 280,317
2022-12-31 $5,093,359 280,317
2022-09-30 $3,809,329 255,317